==== Front BMC Womens Health BMC Womens Health BMC Women's Health 1472-6874 BioMed Central London 2499 10.1186/s12905-023-02499-6 Research The effect of chronic endometritis and treatment on patients with unexplained infertility Gu Juan Sun Qingqing 515571017@qq.com Qi Yujuan Hu Fangfang Cao Yijuan grid.452207.6 0000 0004 1758 0558 Reproductive Medical Center of Xuzhou Central Hospital, 221000 Xuzhou, China 30 6 2023 30 6 2023 2023 23 34514 4 2023 21 6 2023 © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/ Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. Purpose This paper was mainly conducted to investigate the effect of chronic endometritis (CE) on the clinical outcome of patients with unexplained infertility. Materials and methods 145 patients with unexplained infertility from the Reproductive Center of our hospital from January 2018 to December 2021 were selected as the unexplained infertility group. 42 patients with definite infertility causes were selected as the control group during the same period. Both groups of patients underwent hysteroscopy and immunohistochemical tests for CD38 and CD138. According to the results of hysteroscopy and immunohistochemistry, the incidence of CE between the two groups was analyzed. Patients with CE as CE group accepted oral antibiotic therapy for 14 days. Another 58 patients with unexplained infertility who did not undergo hysteroscopy and immunohistochemical tests for CD38 and CD138 were selected as the unexamined group. Both groups of patients were expected natural pregnancy. Follow-up lasted for 1 year, and the pregnant patients were followed up until delivery.The clinical pregnancy rate, spontaneous abortion rate and baby-carrying home rate of the two groups were compared. Results There were 75 patients with CE in the unexplained infertility group, and the prevalence rate was 51.7% (75/145). Compared with the control group (28.6%), the incidence of CE was significantly higher (P < 0.05). After treated with antibiotic treatment, the patients’ clinical pregnancy rate was 61.3% (46/75) and baby-carrying home rate was 60% (45/75) in the CE group, which were higher than those in the unexamined group(43.1% & 36.2%) (P < 0.05), while the spontaneous abortion rate was 2.2% (1/46),which was lower than that in the unexamined group (16.0%) (P < 0.05). Conclusions For patients with unexplained infertility, hysteroscopy combined with endometrial immunohistochemical detection of CD38 and CD138 should be performed in time to exclude CE. The clinical pregnancy outcome of CE patients can be significantly improved by antibiotic treatment. Key words Chronic endometritis Antibiotic treatment Unexplained infertility Pregnancy outcome 2019 Expert Team - Academician Liu Yixun Integrated Traditional Chinese and Western Medicine Obstetrics and Gynecology Reproductive Technology Innovation Team2-2018.11.1 issue-copyright-statement© BioMed Central Ltd., part of Springer Nature 2023 ==== Body pmcIntroduction CE is an inflammation characterized by infiltration of plasma cells in the endometrium. The clinical manifestations are nonspecific or even asymptomatic. However, CE can not only cause pain in the lower abdomen, abnormal uterine bleeding and increased vaginal secretions, but also affect the receptivity of the endometrium, resulting in repeated pregnancy loss, infertility and embryo implantation failure [1]. whether the uterine cavity is diseased, whether the uterine cavity shape is normal, whether the uterine cavity adhesion and endometrial state, etc can be directly observed by hysteroscopy. However, there are some limitations by hysteroscopy and is easily affected by the subjective factors of the surgeon. CD38 and CD138 are specific expression products of plasma cells. The detection rate of endometrial inflammatory lesions can be effectively improved by examing CD38 and CD138 in endometrial tissues [2]. Studies have shown that the diagnostic rate of chronic endometritis can be effectively improved by detecting the positive expressions of CD38 and CD138 in endometrial tissue combined with hysteroscopy [3]. Therefore, we studied the incidence of CE and its effect on clinical pregnancy outcome in patients with unexplained infertility through hysteroscopy combined with the detection of CD38 and CD138 in endometrial tissue. Materials and methods Materials 145 patients with unexplained infertility from the Reproductive Center of our hospital from January 2018 to December 2021 were selected as the unexplained infertility group and 42 patients with definite infertility causes were selected as the control group during the same period. Both groups of patients underwent hysteroscopy and immunohistochemical tests for CD38 and CD138. Patients with unexplained infertility diagnosed as CE were selected as CE group, and another 58 patients with unexplained infertility who didn’t accept hysteroscopy and immunohistochemical tests for CD38 and CD138 were selected as the unexamined group. Inclusion criteria: patients with unexplained infertility and those with clear infertility were younger than 35 years of age. Exclusion criteria: Ovulation disorders, endometriosis, intrauterine adhesions, hypoovarian function, infertility with internal and surgical complications, uterine malformations and organic lesions of the uterus, etc. Methods Hysteroscopy and endometrial acquisition: The hysteroscopy and endometrial biopsy were performed after relevant preoperative examination at 3–7 day after menstruation. Endometrial biopsy plays a key role in the diagnosis of chronic Endometritis [4].The criteria for diagnosing CE under hysteroscopy [5] : (1) Endometrial congestion: dispersed or diffuse congestion, more obvious around the gland; (2) endometrial interstitial edema: the endometrial is still thickened and pale in the proliferation stage; (3) Endometrial polyps: fingerlike protrusions can be seen on the surface of the endometrial. A small curette was used to scratch the endometrium for pathological examination of suspected lesions. Pathological examination and immunohistochemical tests for CD38 and CD138: The endometrial tissues were fixed with 10% formalin solution before being examined. The specimens were routinely dehydrated, embedded in paraffin, sliced and then stained with HE. The criterion for CE determination by HE staining is that typical plasma cells can be seen in the endometrial stroma [6]. Immunohistochemical tests for CD38 and CD138 were performed according to the instructions of the kit. After immunohistochemical staining, at 400 times of high magnification field of view, Five or more typical plasma cells with CD38 and CD138 positive plasma cells and CD38 and CD138 positive glandular epithelial cells found in the endometrial stroma were diagnosed as CE [7]. According to the results of hysteroscopy and immunohistochemistry, the incidence of CE in the two groups was analyzed. Antibiotic treatment: Patients with CE were assigned as CE group and accepted oral antibiotic treatment twice a day for 14 days, doxycycline hydrochloride enteric-coated capsules, 20 capsules/box, 0.1g/ capsule (measured by doxycycline). Comparison of clinical pregnancy outcomes: The paitients in CE group and the unexamined group were monitored for follicles and guided to have sex. The patients were followed up for 1 year, and the pregnant patients were followed up until delivery. The clinical pregnancy rate, spontaneous abortion rate and baby-carrying home rate of the two groups were compared. Statistical analysis IBM SPSS Statistics 26 software was used for statistical analysis of the data. The measurement data were in line with normal distribution, expressed as (\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\bar x \pm s$$\end{document}), and independent sample t test was used. The statistical data were expressed as n (%), and χ2 test or corrected χ2 test was used for comparison between groups. P < 0.05 was considered to be significant. Results Incidence of chronic endometritis in women with unexplained infertility CD38 and CD138 were detected by hysteroscopy and immunohistochemistry in 145 patients with unknown infertility. The results showed that 75 patients with CE and 70 patients without CE, with a prevalence rate of 51.7%, which was significantly higher than that of the control group (28.6%), and the difference was statistically significant (P < 0.05).The results are displayed in Table 1 and Fig. 1 Table 1 Comparison of CE incidence between the two groups [n(%)] Unexplained infertility group(n = 145) Control group (n = 42) P CE(%) 75(51.7) 12(28.6) P = 0.008 Fig. 1 Comparison of the general situation between the CE group and the unexamined group There were no significant differences in age, infertility years, body mass index (IBM), follicle-stimulating hormone (FSH), Luteinizing hormone (LH )and anti-Müllerian hormone (AMH) between the two groups (P > 0.05), indicating that the two groups were comparable (Table 2). Table 2 Comparison of clinical pregnancy rate, spontaneous abortion rate and baby-carrying home rate rate between the CE group and the unexamined group CE group(75) unexamined group(58) P age(years old) 29.20 ± 2.89 28.95 ± 2.95 0.622 infertility years (year) 3.59 ± 1.37 3.26 ± 1.40 0.176 IBM(kg/m2) 21.74 ± 2.49 21.12 ± 2.15 0.134 FSH(mIU/ml) 6.77 ± 1.17 6.92 ± 1.18 0.482 AMH (ng/ml) 3.72 ± 1.41 3.90 ± 1.56 0.472 The clinical pregnancy rate and baby-carrying home rate rate in CE group were 61.3% (46/75) and 60% (45/75) after antibiotic treatment higher than those of the unexamined group (41.3%&36.2%) (P < 0.05), and the spontaneous abortion rate of 2.2% (1/46) was lower than that of the unexamined group (18.2%) (P < 0.05).The results are displayed in Table 3 and Fig. 2 Table 3 Comparison of clinical outcomes between CE group and unexamined group [n(%)] CE group(75) unexamined group(58) P clinical pregnancy (%) 46(61.3) 25(43.1) 0.037 spontaneous abortion(%) 1(2.2) 4(16.0) 0.049 baby-carrying home rate(%) 45(60.0) 21(36.2) 0.006 Fig. 2 Comparison of clinical outcomes between CE group and unexamined group Discussion In recent years, the research about CE and infertility has attracted more and more attention from reproductive clinicians. It has been reported that the prevalence rate of CE in infertile patients is 2.8%~30% [8]. However, it was as high as 67.5% in patients with unexplained recurrent abortion or repeated embryo implantation failure [1]. Although the clinical treatment of infertility patients has greatly improved through cell and gene therapies, there are still some patients who experience repeated implantation failures [9].The study showed that mild CE had no effect on the IVF outcome, but women with severe CE had lower ongoing-pregnancy rate/live-birth-rate (OR 0.43, p = 0.003) and clinical-pregnancy rate (OR 0.40, p = 0.0007) [10].More and more studies believe that CE changes the endometrial microenvironment and thus affects endometrial receptivity, leading to the occurrence of adverse pregnancy. It is easy to miss the CE diagnosis because there is no specific clinical and laboratory diagnosis method. At present, the commonly used detection methods include hysteroscopy, histopathology, microbial culture and so on. Because there is certain clinical subjectivity and limitations about the diagnosis of hysteroscopy, hysteroscopy combined with endometrial immunohistochemistry was adopted in this study to detect CD38 and CD138, which significantly improved the diagnosis rate of CE. This is consistent with Bouet’s views [11]. Bouet’s study showed that the sensitivity and specificity of hysteroscopy in the CE diagnosis were 40% (8/20) and 80%(59/74) and believed that hysteroscopy combined with endometrial biopsy was an effective means of CE diagnosis. Diagnosis and treatment of bacterial vaginosis, chronic endometritis, and pelvic inflammatory disease prior to attempted conception may be an important part of preconception care for symptomatic women to improve outcomes of natural and assisted reproduction [12]. Multiple embryo transfers, prolonged menstruation and in vitro fertilization-embryo transfer (IVF-ET) increased the risk of endometrial bacterial infection. Patients with tubal obstruction had an increased probability of secondary infection, which was related to endometrial inflammatory reaction and was a risk factor for CE [3, 13]. Therefore, the above patients should also be examined in time to rule out CE, and timely antibiotics should be given to those patients with CE, so as to improve the clinical pregnancy outcome.The transient, repeated and persistent impaired inflammatory state of the endometrium is a major factor of most problematic disorders in obstetrics/gynecology, such as endometrial polyps, unexplained infertility, miscarriage. The concept of impaired inflammatory state of the endometrium considers both infectious and non-infectious etiology and provids a newer approach to defective endometrial inflammation [14]. As for the treatment of endometritis, oral antibiotics are the commonly used treatment method at present. After treated with antibiotics, 82.3% of CE patients underwent re-histological examination, and the clinical pregnancy rate and live birth rate of cured patients were higher than those of uncured patients and those without CE detection [15]. Effective antibiotic treatment for chronic endometritis may improve the clinical pregnancy rate and live birth rate with unexplained recurrent pregnancy loss (RPL), and increase the ongoing pregnancy rate in patients with recurrent implantation failure [16]. A study of the effects of antibiotic therapy on obstetric outcomes in patients with RPL showed that live birth rates in patients with chronic endometritis improved after 14 days of antibiotic therapy compared to untreated chronic endometritis [17]. In this study, the clinical pregnancy rate and baby-carrying home rate rate of CE patients with unexplained infertility after antibiotic treatment were significantly higher than those of the unexamined group, while the spontaneous abortion rate was lower than that of the unexamined group. The incidence of chronic endometritis is very high in patients with unexplained infertility. Timely diagnosis and treatment of chronic endometrial inflammation can significantly improve the natural pregnancy rate and baby-carrying home rate of patients. Patients with unexplained infertility experience a variety of examination and treatment failure, psychological pressure is greater. Timely searching for the causes of infertility and treatment, not only can improve the patient’s pregnancy outcome, but also greatly alleviate the patient’s mental anxiety, contribute to the stability of the family and society. Acknowledgements The authors thank the colleague for their contribution in sample and data collection. Author contributions Juan Gu and Qingqing Sun conceived and designed the study. Juan Gu, Yujuan Qi and Yijuan Cao was responsible for collecting cases. Juan Gu, Qingqing Sun and Yujuan Qi performed the operation. Qingqing Sun and Fangfang Hu conducted the statistical analysis. All authors reviewed and approved the final version of the manuscript. Funding Not applicable. Availability of data and materials The study results were included in this published article. Declarations Statement All methods were carried out in accordance with relevant guidelines and regulations. Ethics approval and consent to participate The patients were given informed consent about the above treatment and The study was approved by the Reproductive Medicine Ethics Committee of Xuzhou Central Hospital. Consent for publication Not applicable. Competing interests The authors declare that they have no competing interests. Abbreviations CE chronic endometritis IBM Body mass index FSH Follicle-stimulating hormone LH Luteinizing hormone AMH Anti-Müllerian hormone RPL Recurrent pregnancy loss IVF-ET In vitro fertilization and embryo transfer Publisher’s Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. ==== Refs References 1. Kimura F Takebayashi A Ishida M Review: Chronic endometritis and its effect on reproduction [J] J Obstet Gynaecol Res 2019 45 5 951 60 10.1111/jog.13937 30843321 2. Zargar M Ghafourian M Nikbakht R Mir Hosseini V Moradi Choghakabodi P Evaluating Chronic Endometritis in Women with Recurrent Implantation Failure and Recurrent Pregnancy Loss by Hysteroscopy and Immunohistochemistry J Minim Invasive Gynecol 2020 27 1 116 21 10.1016/j.jmig.2019.02.016 30851430 3. Li Xi-ya Dong-mei ZHAO Jie ZHANG Value of CD138 positive expression combined with hysteroscopy to the diagnosis of in vitro fertilization-embryo transfer repeated implantation failure complicated with chronic endometritis J Chin Pract Diagn The 2022 36 02 168 72 4. Vitale SG Buzzaccarini G Riemma G Endometrial biopsy: Indications, techniques and recommendations. An evidence-based guideline for clinical practice J Gynecol Obstet Hum Reprod 2023 52 6 102588 10.1016/j.jogoh.2023.102588 37061093 5. Cicinelli E Vitagliano A Kumar A International Working Group for Standardization of Chronic Endometritis Diagnosis. Unified diagnostic criteria for chronic endometritis at fluid hysteroscopy: proposal and reliability evaluation through an international randomized-controlled observer study Fertil Steril 2019 112 1 162 73 10.1016/j.fertnstert.2019.03.004 31104760 6. Sfakianoudis K Simopoulou M Nitsos N Successful Implantation and Live Birth Following Autologous Platelet-rich Plasma Treatment for a Patient with Recurrent Implantation Failure and Chronic Endometritis Vivo 2019 33 2 515 21 10.21873/invivo.11504 7. Adegboyega PA Pei Y McLarty J Relationship between eosinophils and chronic endometritis Hum Pathol 2010 41 1 33 7 10.1016/j.humpath.2009.07.008 19801162 8. Kitaya K Takeuchi T Mizuta S Endometritis: new time, new concepts [J] Fertil Steril 2018 110 3 344 50 10.1016/j.fertnstert.2018.04.012 29960704 9. Medenica S, Abazovic D, Ljubić A et al. The Role of Cell and Gene Therapies in the Treatment of Infertility in Patients with Thyroid Autoimmunity. Int J Endocrinol. 2022, 4842316. 10. Vitagliano A Laganà AS De Ziegler D Chronic Endometritis in Infertile Women: Impact of Untreated Disease, Plasma Cell Count and Antibiotic Therapy on IVF Outcome-A Systematic Review and Meta-Analysis Diagnostics (Basel) 2022 12 9 2250 10.3390/diagnostics12092250 36140651 11. Bouet PE El Hachem H Monceau E Chronic endometritis in women with recurrent pregnancy loss and recurrent implantation failure: prevalence and role of office hysteroscopy and immunohistochemistry in diagnosis Fertil Steril 2016 105 1 106 10 10.1016/j.fertnstert.2015.09.025 26456229 12. Ravel J Moreno I Simón C Bacterial vaginosis and its association with infertility, endometritis, and pelvic inflammatory disease Am J Obstet Gynecol 2021 224 3 251 7 10.1016/j.ajog.2020.10.019 33091407 13. Martingano D Renson A Rogoff S Daily gentamicin using ideal body weight demonstrates lower risk of postpartum endometritis and increased chance of successful outcome compared with traditional 8-hour dosing for the treatment of intrapartum chorioamnionitis J Matern Fetal Neonatal Med 2019 32 19 3204 8 10.1080/14767058.2018.1460348 29642754 14. Drizi A Djokovic D Laganà AS Impaired inflammatory state of the endometrium: a multifaceted approach to endometrial inflammation. Current insights and future directions Prz Menopauzalny 2020 19 2 90 100 32802019 15. Cicinelli E Matteo M Trojano G Chronic endometritis in patients with unexplained infertility: Prevalence and effects of antibiotic treatment on spontaneous conception Am J Reprod Immunol 2018 79 1 e12782 10.1111/aji.12782 16. Puente E Alonso L Laganà AS Chronic Endometritis: Old Problem, Novel Insights and Future Challenges Int J Fertil Steril 2020 13 4 250 6 31710184 17. Gay C Hamdaoui N Pauly V Rojat Habib MC Djemli A Carmassi M Chau C Bretelle F Impact of antibiotic treatment for chronic endometritis on unexplained recurrent pregnancy loss J Gynecol Obstet Hum Reprod 2021 50 5 102034 10.1016/j.jogoh.2020.102034 33307243